GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Esophageal squamous cell carcinoma tissue array, grade I_III, 40 cases_80 cores, no overlaps with ES801 / Product Detail : ES802 Esophageal squamous cell carcinoma tissue array, grade I_III, 40 cases_80 cores, no overlaps with ES801
#ES802 Esophageal squamous cell carcinoma tissue array, grade I_III, 40 cases_80 cores, no overlaps with ES801
Product name : Esophageal squamous cell carcinoma tissue array, grade I_III, 40 cases_80 cores, no overlaps with ES801
Catalog number : ES802
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
More Details about
|Microarray Panel:||Esophagus carcinoma tissue microarray, duplicated cores per case, 30 cases of esophageal squamous cancer in grade 1~3, 3 cases of real normal and 2 cases of tumor adjacent normal tissue|
|Layout:||10 cols × 8 rows|
|Core Diameter:||1.5 mm|
|Quality Control:||Anti-Cytokeratin (CK) confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Esophageal squamous cell carcinoma tissue array, grade I_III, 40 cases_80 cores, no overlaps with ES801
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP2006: Squamous cell TarBase
WP1011: T Cell Receptor Signaling Pathway
WP1025: B Cell Receptor Signaling Pathway
WP1043: Calcium Regulation in the Cardiac Cell
WP1069: Integrin-mediated cell adhesion
WP1078: G1 to S cell cycle control
WP1083: Cell cycle
WP1130: T Cell Receptor Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP1159: Calcium Regulation in the Cardiac Cell
WP1185: Integrin-mediated cell adhesion
WP1195: G1 to S cell cycle control
WP1200: Cell cycle
WP1345: T Cell Receptor Signaling Pathway
WP1354: B Cell Receptor Signaling Pathway
WP1365: Calcium Regulation in the Cardiac Cell
WP1386: Integrin-mediated cell adhesion
WP1393: Cell cycle
WP1411: Cell Division: First embryonic mitosis
WP1775: Cell Cycle Checkpoints
WP1782: APC/C-mediated degradation of cell cycle proteins
WP179: Cell cycle
WP1792: Cell Cycle, Mitotic
WP1793: Cell junction organization
WP1794: Cell surface interactions at the vascular wall
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[LZTS1 FEZ1] Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1)
[TGFBR2] TGF-beta receptor type-2 (TGFR-2) (EC 188.8.131.52) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)
[DLEC1 DLC1] Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1)
[ALOX12 12LO LOG12] Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 184.108.40.206) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)
[TMPRSS11A ECRG1 HATL1 HESP] Transmembrane protease serine 11A (EC 3.4.21.-) (Airway trypsin-like protease 1) (Epidermal type-II transmembrane serine protease) (Esophageal cancer-susceptibility gene 1 protein)
[RHOA ARH12 ARHA RHO12] Transforming protein RhoA (Rho cDNA clone 12) (h12)
[WWOX FOR SDR41C1 WOX1] WW domain-containing oxidoreductase (EC 1.1.1.-) (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1)
[CLE1 2B10 HSP1 SYV46] CLAVATA3/ESR (CLE)-related protein 1 (CLE-like peptide 1) (Hg-SYV46) (Esophageal gland cell secretory protein 1)
[RNF6 SPG2] E3 ubiquitin-protein ligase RNF6 (EC 6.3.2.-)
[DMBT1 GP340] Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)
[SOX2] Transcription factor SOX-2
[FGF8 AIGF] Fibroblast growth factor 8 (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8)
[CASP8 MCH5] Caspase-8 (CASP-8) (EC 220.127.116.11) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]
[Lzts1 Fez1] Leucine zipper putative tumor suppressor 1 (F37/Esophageal cancer-related gene-coding leucine-zipper motif) (Fez1)
[C16orf62 101F10.2] UPF0505 protein C16orf62 (Esophageal cancer-associated protein)
[Ecrg4] Augurin (Esophageal cancer-related gene 4 protein homolog)
[CDKN2A CDKN2 MTS1] Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A) (CDK4I) (Multiple tumor suppressor 1) (MTS-1) (p16-INK4a) (p16-INK4) (p16INK4A)
[GRB7] Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein)
[FZD4] Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344)
[LTA4H LTA4] Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 18.104.22.168) (Leukotriene A(4) hydrolase)
[YAP1 YAP65] Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)
[16D10 MSP16] CLAVATA3/ESR (CLE)-related protein 16D10 (Esophageal gland cell secretory protein 16)
[Ecrg4] Augurin (Esophageal cancer-related gene 4 protein homolog)
[C2orf40 ECRG4 UNQ761/PRO1508] Augurin (Esophageal cancer-related gene 4 protein)
[AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6] Aurora kinase A (EC 22.214.171.124) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)
[FZD5 C2orf31] Frizzled-5 (Fz-5) (hFz5) (FzE5)
[MSR1 SCARA1] Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204)
[NLRP3 C1orf7 CIAS1 NALP3 PYPAF1] NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)
 A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
 A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.
 Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
 Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.
 Management of long post-radiation esophageal strictures by means of endoscopic submucosal dissection.
 Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma.
 Antireflux versus conventional self-expanding metallic Stents (SEMS) for distal esophageal cancer: results of a multicenter randomized trial.
 Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett's esophagus: a Western center experience.
 Biodegradable esophageal stents in benign and malignant strictures - a single center experience.
 Idiopathic noncirrhotic portal hypertension: current perspectives.
Enter catalog number :